Department of Orthopaedics, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen, Guangdong Province 518055, China.
Curr Stem Cell Res Ther. 2020;15(7):597-601. doi: 10.2174/1574888X15666200206104332.
Osteoarthritis(OA) is a common degenerative orthopedic disease with multiple pathologic changes in joints affecting large populations worldwide. No treatment can reverse the progress of OA. Since exosomes were first reported in 1983, researches have been conducted to explore the mechanisms and therapeutic potential of exosomes in treating OA. Exosomes derived from Mesenchymal stem cells have attracted increasing attention in tackling the disease. This article summarizes the current advances and challenges in exosomes for OA, which may providea reference for further research.
骨关节炎(OA)是一种常见的退行性骨科疾病,关节的多种病理变化影响着全球的大量人群。目前尚无治疗方法可以逆转 OA 的进展。自 1983 年首次报道外泌体以来,研究人员一直在探索外泌体在治疗 OA 中的作用机制和治疗潜力。间充质干细胞来源的外泌体在治疗该疾病方面引起了越来越多的关注。本文总结了外泌体在 OA 治疗方面的最新进展和挑战,为进一步的研究提供参考。